Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen, covering 2017-04-10 to 2017-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents [Phase 2, Phase 3]